W A Wohlgemuth1, W Uller, R Müller-Wille. 1. Institut für Röntgendiagnostik, Universitätsklinikum Regensburg, Franz-Josef-Strauß-Allee 1, Regensburg, Germany. walter.wohlgemuth@ukr.de
Abstract
CLINICAL/METHODICAL ISSUE: Liquid embolic agents are used for permanent occlusion of capillaries but optimal administration properties are lacking. STANDARD RADIOLOGICAL METHODS: The lack of visualization by fluoroscopy and the risk of serious complications are disadvantages of conventional embolic agents, such as ethanol and Histoacryl. METHODICAL INNOVATIONS: Onyx is a liquid embolic agent consisting of ethylene vinyl alcohol copolymer dissolved in various concentrations of dimethyl sulfoxide (DMSO) and suspended micronized tantalum powder to provide contrast for fluoroscopy. PERFORMANCE: The physicochemical characteristics of Onyx allow controlled application, forming a defined cast and permanent occlusion. Disadvantages are the high costs. Furthermore, the solvent DMSO requires special catheter material and causes pain during Onyx application. ACHIEVEMENTS: Onyx has been primarily used for interventional neuroradiological treatment but peripheral applications are becoming increasingly more common. PRACTICAL RECOMMENDATIONS: Currently, Onyx is mainly used for embolotherapy of endoleaks after endovascular aortic aneurysm repair, for treatment of acute arterial bleeding and for treatment of arteriovenous malformations.
CLINICAL/METHODICAL ISSUE: Liquid embolic agents are used for permanent occlusion of capillaries but optimal administration properties are lacking. STANDARD RADIOLOGICAL METHODS: The lack of visualization by fluoroscopy and the risk of serious complications are disadvantages of conventional embolic agents, such as ethanol and Histoacryl. METHODICAL INNOVATIONS: Onyx is a liquid embolic agent consisting of ethylene vinyl alcohol copolymer dissolved in various concentrations of dimethyl sulfoxide (DMSO) and suspended micronized tantalum powder to provide contrast for fluoroscopy. PERFORMANCE: The physicochemical characteristics of Onyx allow controlled application, forming a defined cast and permanent occlusion. Disadvantages are the high costs. Furthermore, the solvent DMSO requires special catheter material and causes pain during Onyx application. ACHIEVEMENTS: Onyx has been primarily used for interventional neuroradiological treatment but peripheral applications are becoming increasingly more common. PRACTICAL RECOMMENDATIONS: Currently, Onyx is mainly used for embolotherapy of endoleaks after endovascular aortic aneurysm repair, for treatment of acute arterial bleeding and for treatment of arteriovenous malformations.
Authors: Flavio Castaneda; Scott C Goodwin; James L Swischuk; Gordon C H Wong; Sheila M Bonilla; Mark J Wang; Peter S Abdel-Sayed Journal: J Vasc Interv Radiol Date: 2002-05 Impact factor: 3.464
Authors: Maarten L J Smits; Peter Vanlangenhove; Emiel J C Sturm; Maurice A A J van den Bosch; Monirath Hav; Marleen Praet; Maarten A D Vente; Frédéric R Snaps; Luc Defreyne Journal: Cardiovasc Intervent Radiol Date: 2011-10-07 Impact factor: 2.740
Authors: Kamal Massis; William G Carson; Alexandra Rozas; Vishal Patel; Bruce Zwiebel Journal: Vasc Endovascular Surg Date: 2012-04-09 Impact factor: 1.089
Authors: V Guralnik; A Schäffler; J Schölmerich; H J Schlitt; R Müller-Wille; S Feuerbach; F Obermeier Journal: Dtsch Med Wochenschr Date: 2008-09-10 Impact factor: 0.628
Authors: Terhi Nevala; Fausto Biancari; Hannu Manninen; Pekka-Sakari Aho; Pekka Matsi; Kimmo Mäkinen; Wolf-Dieter Roth; Kari Ylönen; Mauri Lepäntalo; Jukka Perälä Journal: Cardiovasc Intervent Radiol Date: 2009-08-18 Impact factor: 2.740
Authors: Ghassan Nakib; Valeria Calcaterra; Pietro Quaretti; Lorenzo Paolo Moramarco; Giovanni Bonalumi; Marco Brunero; Gloria Pelizzo Journal: Case Rep Oncol Date: 2014-01-10